Home » Posts tagged 'primary prevention'

Tag Archives: primary prevention

Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages

VITAL: N3 fatty acid supplements for prevention of CVD and cancer

2018, N3 fatty acid supplements for prevention of CVD and cancer, NEJM

VITAL: Vitamin D3 for prevention of CVD and cancer

2018, Vitamin D3 for prevention of CVD and cancer, NEJM

ASCEND: Aspirin for primary prevention in patients with Diabetes

2018, Aspirin for primary prevention in patients with Diabetes mellitus, NEJM

ARRIVE Trial: Aspirin for Primary Prevention in Adults at Moderate Cardiovascular Risk

 

2018, Effect of Aspirin in elderly at moderate CVD risk | LANCET

ASPREE Trial: Aspirin for Primary Prevention in Healthy Adults

2018, Effect of Aspirin on CV Events and Bleeding in the Healthy Elderly | NEJM

USPSTF/ACC/AHA guidelines for Statin Use for the Primary Prevention of Cardiovascular Disease in Adults

The USPSTF and ACC/AHA guidelines for statin use in adults aged 40-75 years are consistent over level of recommendation. Adults who have no history of cardiovascular disease but have 1 or more risk factors for developing CVD along with >10% ASCVD risk are recommended to be started on low- to moderate dose statin. (USPSTF = B). The ACC/AHA however recommends moderate to high dose statin for ASCVD risk of >7.5% for primary prevention (ACC/AHA Level I). The above visual abstract summarizes both the societies’ recommendations in to one easy to use graphic.

UPSTF Source, ACC/AHA source

Subscribe via email